Concepedia

Sebastian Schellong

SS

130

Publications

15.7K

Citations

49

H-Index

1988

Active since

Affiliations

Harvard University(Current)

Städtisches Klinikum Dresden

McMaster University

Thrombosis Research Institute

Brigham and Women's Hospital

Sebastian Schellong is an author at Harvard University specializing in medicine, thrombosis, and cardiovascular disease.

ORCID

Top concepts

Publications per year

1988–2025

130

Publications

130

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2009 · 2.5K citations · Full text

Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism

Guy Meyer, Éric Vicaut, Thierry Danays et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2013 · 977 citations · Full text

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Sam Schulman, Ajay K. Kakkar, Samuel Z. Goldhaber et al. · Circulation · 2013 · 923 citations · Full text

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

, , +13

Rows per page

1–5 of 130